These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28757159)

  • 1. Effectivity of oral recombinant DNA vaccine against Streptococcus agalactiae in Nile tilapia.
    Zhu L; Yang Q; Huang L; Wang K; Wang X; Chen D; Geng Y; Huang X; Ouyang P; Lai W
    Dev Comp Immunol; 2017 Dec; 77():77-87. PubMed ID: 28757159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and immunogenicity of an oral DNA vaccine encoding Sip of Streptococcus agalactiae from Nile tilapia Oreochromis niloticus delivered by live attenuated Salmonella typhimurium.
    Huang LY; Wang KY; Xiao D; Chen DF; Geng Y; Wang J; He Y; Wang EL; Huang JL; Xiao GY
    Fish Shellfish Immunol; 2014 May; 38(1):34-41. PubMed ID: 24631734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective efficacy of cationic-PLGA microspheres loaded with DNA vaccine encoding the sip gene of Streptococcus agalactiae in tilapia.
    Ma YP; Ke H; Liang ZL; Ma JY; Hao L; Liu ZX
    Fish Shellfish Immunol; 2017 Jul; 66():345-353. PubMed ID: 28476676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-immunity in Nile tilapia vaccinated with Streptococcus agalactiae and Streptococcus iniae vaccines.
    Wang Q; Fu T; Li X; Luo Q; Huang J; Sun Y; Wang X
    Fish Shellfish Immunol; 2020 Feb; 97():382-389. PubMed ID: 31841691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response and protective efficacy of two new adjuvants, Montanide™ ISA 763B VG and Montanide™ GEL02, administered with a Streptococcus agalactiae ghost vaccine in Nile tilapia (Oreochromis niloticus).
    Wangkaghart E; Deville S; Wang B; Srisapoome P; Wang T; Secombes CJ
    Fish Shellfish Immunol; 2021 Sep; 116():19-29. PubMed ID: 34153428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Streptococcus agalactiae (group B) vaccine in tilapia (Oreochromis niloticus) by intraperitoneal and bath immersion administration.
    Evans JJ; Klesius PH; Shoemaker CA
    Vaccine; 2004 Sep; 22(27-28):3769-73. PubMed ID: 15315858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a novel Streptococcus agalactiae ghost vaccine and examination of its immunogenicity against virulent challenge in tilapia.
    Wang Q; Wang X; Wang X; Feng R; Luo Q; Huang J
    Fish Shellfish Immunol; 2018 Oct; 81():49-56. PubMed ID: 29969706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphoglycerate kinase enhanced immunity of the whole cell of Streptococcus agalactiae in tilapia, Oreochromis niloticus.
    Wang YT; Huang HY; Tsai MA; Wang PC; Jiang BH; Chen SC
    Fish Shellfish Immunol; 2014 Dec; 41(2):250-9. PubMed ID: 25218275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral vaccination of tilapia against Streptococcus agalactiae using Bacillus subtilis spores expressing Sip.
    Yao YY; Chen DD; Cui ZW; Zhang XY; Zhou YY; Guo X; Li AH; Zhang YA
    Fish Shellfish Immunol; 2019 Mar; 86():999-1008. PubMed ID: 30590166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive evaluation of immunomodulation by moderate hypoxia in S. agalactiae vaccinated Nile tilapia.
    Gallage S; Katagiri T; Endo M; Maita M
    Fish Shellfish Immunol; 2017 Jul; 66():445-454. PubMed ID: 28526572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of live attenuated Streptococcus agalactiae vaccine for tilapia via continuous passage in vitro.
    Li LP; Wang R; Liang WW; Huang T; Huang Y; Luo FG; Lei AY; Chen M; Gan X
    Fish Shellfish Immunol; 2015 Aug; 45(2):955-63. PubMed ID: 26087276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic appraisal of vaccination against Streptoccocus agalactiae in Nile tilapia farms in Brazil.
    Delphino MKVC; Barone RSC; Leal CAG; Figueiredo HCP; Gardner IA; Gonçalves VSP
    Prev Vet Med; 2019 Jan; 162():131-135. PubMed ID: 30621892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of novel antigenic vaccine candidates for nile tilapia (Oreochromis niloticus) against Streptococcus agalactiae infection.
    Ma Y; Hao L; Liang Z; Ma J; Ke H; Kang H; Yang H; Wu J; Feng G; Liu Z
    Fish Shellfish Immunol; 2020 Oct; 105():405-414. PubMed ID: 32712231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Streptococcus agalactiae vaccines for tilapia.
    Liu G; Zhu J; Chen K; Gao T; Yao H; Liu Y; Zhang W; Lu C
    Dis Aquat Organ; 2016 Dec; 122(2):163-170. PubMed ID: 28000606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An effective live attenuated vaccine against Streptococcus agalactiae infection in farmed Nile tilapia (Oreochromis niloticus).
    Zhang D; Gao Y; Li Q; Ke X; Liu Z; Lu M; Shi C
    Fish Shellfish Immunol; 2020 Mar; 98():853-859. PubMed ID: 31751658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of intermittent hypoxia under different temperature on the immunomodulation in Streptococcus agalactiae vaccinated Nile tilapia (Oreochromis niloticus).
    Wang J; Lu DQ; Jiang B; Luo HL; Lu GL; Li AX
    Fish Shellfish Immunol; 2018 Aug; 79():181-192. PubMed ID: 29684601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of live attenuated Streptococcus agalactiae as potential vaccines by selecting for resistance to sparfloxacin.
    Pridgeon JW; Klesius PH
    Vaccine; 2013 May; 31(24):2705-12. PubMed ID: 23583891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled and targeted release of antigens by intelligent shell for improving applicability of oral vaccines.
    Zhang L; Zeng Z; Hu C; Bellis SL; Yang W; Su Y; Zhang X; Wu Y
    Biomaterials; 2016 Jan; 77():307-19. PubMed ID: 26624805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening vaccine candidate strains against Streptococcus agalactiae of tilapia based on PFGE genotype.
    Chen M; Wang R; Li LP; Liang WW; Li J; Huang Y; Lei AY; Huang WY; Gan X
    Vaccine; 2012 Sep; 30(42):6088-92. PubMed ID: 22867719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of attenuated erythromycin-resistant Streptococcus agalactiae vaccine for tilapia (Oreochromis niloticus) culture.
    Liu L; Lu DQ; Xu J; Luo HL; Li AX
    J Fish Dis; 2019 May; 42(5):693-701. PubMed ID: 30893488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.